{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:47:31Z","timestamp":1759340851007},"reference-count":37,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1684\/bdc.2014.2021","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T20:02:13Z","timestamp":1565726533000},"page":"881-890","source":"Crossref","is-referenced-by-count":2,"title":["Lymphome de Hodgkin nodulaire \u00e0 pr\u00e9dominance lymphocytaire chez l\u2019enfant: pr\u00e9sentation clinique, biologique et prise en charge actuelle"],"prefix":"10.1016","volume":"101","author":[{"given":"St\u00e9phanie","family":"Gorde-Grosjean","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gr\u00e9gory","family":"Guimard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Lambilliotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurore","family":"Coulomb-lhermine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Montravers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Landman-Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1684\/bdc.2014.2021_bib0005","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"439","author":"Swerdlow","year":"2008"},{"key":"10.1684\/bdc.2014.2021_bib0010","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00043426-200205000-00010","article-title":"Lymphocyte-predominant Hodgkin disease in children","volume":"24","author":"Sandoval","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1684\/bdc.2014.2021_bib0015","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1365-2141.2007.06736.x","article-title":"Outcome of children with nodular lymphocyte predominant Hodgkin lymphoma - a Children's Cancer and Leukaemia Group report","volume":"138","author":"Hall","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1684\/bdc.2014.2021_bib0020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/cncr.22762","article-title":"Resection alone in 58children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma","volume":"110","author":"Mauz-K\u00f6rholz","year":"2007","journal-title":"Cancer"},{"key":"10.1684\/bdc.2014.2021_bib0025","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/bjh.12055","article-title":"Nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents--a comprehensive review of biology, clinical course and treatment options","volume":"159","author":"Shankar","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1684\/bdc.2014.2021_bib0030","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/(SICI)1096-911X(199712)29:6<519::AID-MPO1>3.0.CO;2-N","article-title":"Lymphocyte predominant Hodgkin disease: clinico-pathologic features and results of treatment--the Pediatric Oncology Group experience","volume":"29","author":"Karayalcin","year":"1997","journal-title":"Med Pediatr Oncol"},{"key":"10.1684\/bdc.2014.2021_bib0035","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1200\/JCO.2012.43.5958","article-title":"High familial risk in nodular lymphocyte-predominant Hodgkin lymphoma","volume":"31","author":"Saarinen","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2014.2021_bib0040","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting","volume":"7","author":"Lister","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2014.2021_bib0045","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.1684\/bdc.2014.2021_bib0050","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/jcp.55.3.162","article-title":"Hodgkin's lymphoma: the pathologist's viewpoint","volume":"55","author":"Pileri","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1684\/bdc.2014.2021_bib0055","first-page":"257","article-title":"Lymphocyte-predominance Hodgkin's disease","volume":"9","author":"Poppema","year":"1992","journal-title":"Semin Diagn Pathol"},{"key":"10.1684\/bdc.2014.2021_bib0060","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0242-6498(04)93937-5","article-title":"Nodular lymphocyte predominance Hodgkin's disease and its differential diagnosis","volume":"24","author":"Carbonnelle","year":"2004","journal-title":"Ann Pathol"},{"key":"10.1684\/bdc.2014.2021_bib0065","first-page":"1889","article-title":"European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes","volume":"96","author":"Anagnostopoulos","year":"2000","journal-title":"Blood"},{"key":"10.1684\/bdc.2014.2021_bib0070","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1200\/JCO.1999.17.3.776","article-title":"Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease","volume":"17","author":"Diehl","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2014.2021_bib0075","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJM199708143370704","article-title":"Clonality in nodular lymphocyte-predominant Hodgkin's disease","volume":"337","author":"Ohno","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1684\/bdc.2014.2021_bib0080","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1182\/blood-2011-03-341560","article-title":"Exome sequencing reveals germline NPAT mutation as a candidate risk factor for Hodgkin lymphoma","volume":"118","author":"Saarinen","year":"2011","journal-title":"Blood"},{"key":"10.1684\/bdc.2014.2021_bib0085","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.annpat.2012.07.021","article-title":"Pitfalls and update in haematopathology. Case 7. Nodular lymphocyte predominant Hodgkin lymphoma","volume":"32","author":"Moreau","year":"2012","journal-title":"Ann Pathol"},{"key":"10.1684\/bdc.2014.2021_bib0090","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00000478-198404000-00002","article-title":"Differential diagnostic features of nodular L & H Hodgkin's disease, including progressive transformation of germinal centers","volume":"8","author":"Burns","year":"1984","journal-title":"Am J Surg Pathol"},{"key":"10.1684\/bdc.2014.2021_bib0095","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s00247-003-1114-3","article-title":"PET imaging in pediatric Hodgkin's lymphoma","volume":"34","author":"Hudson","year":"2004","journal-title":"Pediatr Radiol"},{"key":"10.1684\/bdc.2014.2021_bib0100","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3324\/haematol.11661","article-title":"18-F FDG-PET in the staging of lymphocyte-predominant Hodgkin's disease","volume":"93","author":"Ansquer","year":"2008","journal-title":"Haematologica"},{"key":"10.1684\/bdc.2014.2021_bib0105","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/hon.782","article-title":"Different histopathological subtypes of Hodgkin lymphoma show significantly different levels of FDG uptake","volume":"24","author":"Hutchings","year":"2006","journal-title":"Hematol Oncol"},{"key":"10.1684\/bdc.2014.2021_bib0110","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s12149-012-0665-5","article-title":"Role of F-18FDG PET\/CT in assessing bone marrow involvement in pediatric Hodgkin's lymphoma","volume":"27","author":"Agrawal","year":"2013","journal-title":"Ann Nucl Med"},{"key":"10.1684\/bdc.2014.2021_bib0115","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1200\/JCO.2007.11.8869","article-title":"Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group","volume":"26","author":"Nogov\u00e1","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2014.2021_bib0120","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1182\/blood-2013-07-515825","article-title":"The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)","volume":"122","author":"Hartmann","year":"2013","journal-title":"Blood"},{"key":"10.1684\/bdc.2014.2021_bib0125","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1200\/JCO.2003.01.079","article-title":"Lymphocyte-predominant Hodgkin's lymphoma in children: therapeutic abstention after initial lymph node resection--a Study of the French Society of Pediatric Oncology","volume":"21","author":"Pellegrino","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2014.2021_bib0130","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/cncr.21303","article-title":"Long-term outcome after radiotherapy alone for lymphocyte-predominant Hodgkin lymphoma: a retrospective multicenter study of the Australasian Radiation Oncology Lymphoma Group","volume":"104","author":"Wirth","year":"2005","journal-title":"Cancer"},{"key":"10.1684\/bdc.2014.2021_bib0135","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1200\/JCO.2009.24.0945","article-title":"Early-stage, lymphocyte-predominant Hodgkin's lymphoma: patient outcomes from a large, single-institution series with long follow-up","volume":"28","author":"Chen","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2014.2021_bib0140","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1182\/blood-2011-07-365932","article-title":"Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome","volume":"118","author":"Savage","year":"2011","journal-title":"Blood"},{"key":"10.1684\/bdc.2014.2021_bib0145","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.ejca.2011.10.018","article-title":"Treatment outcome after low intensity chemotherapy [CVP] in children and adolescents with early stage nodular lymphocyte predominant Hodgkin's lymphoma - an Anglo-French collaborative report","volume":"48","author":"Shankar","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1684\/bdc.2014.2021_bib0150","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1182\/blood-2002-08-2644","article-title":"Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2trial","volume":"101","author":"Ekstrand","year":"2003","journal-title":"Blood"},{"key":"10.1684\/bdc.2014.2021_bib0155","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000177953","article-title":"Rituximab in lymphocyte-predominant Hodgkin disease","volume":"76","author":"Azim","year":"2009","journal-title":"Oncology"},{"key":"10.1684\/bdc.2014.2021_bib0160","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1182\/blood-2013-07-453241","article-title":"How I treat nodular lymphocyte predominant Hodgkin lymphoma","volume":"122","author":"Advani","year":"2013","journal-title":"Blood"},{"key":"10.1684\/bdc.2014.2021_bib0165","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1182\/blood-2007-03-078725","article-title":"Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2trial by the German Hodgkin Lymphoma Study Group (GHSG)","volume":"111","author":"Schulz","year":"2008","journal-title":"Blood"},{"key":"10.1684\/bdc.2014.2021_bib0170","first-page":"991","article-title":"High-dose chemotherapy and autologous stem cell transplantation for nodular lymphocyte-predominant Hodgkin lymphoma","volume":"19","author":"Karuturi","year":"2013","journal-title":"bbmt"},{"key":"10.1684\/bdc.2014.2021_bib0175","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1200\/JCO.2009.24.9516","article-title":"Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin's lymphoma","volume":"28","author":"Al-Mansour","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2014.2021_bib0180","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/cncr.24819","article-title":"Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164patients from the Adult Lymphoma Study Group","volume":"116","author":"Biasoli","year":"2010","journal-title":"Cancer"},{"key":"10.1684\/bdc.2014.2021_bib0185","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.clml.2013.03.004","article-title":"Does functional imaging distinguish nodular lymphocyte-predominant hodgkin lymphoma from T-cell\/histiocyte-rich large B-cell lymphoma?","volume":"13","author":"Barber","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115300448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115300448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T08:20:12Z","timestamp":1602490812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455115300448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0007455115300448"],"URL":"https:\/\/doi.org\/10.1684\/bdc.2014.2021","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}